Education
About Us
Working with TipRanks
Follow Us
Rapport Therapeutics, Inc. (RAPP)
NASDAQ:RAPP
| Dec 24 | Dec 23 | Dec 22 | |
|---|---|---|---|
| Income Statement | |||
| Total Revenue | $ 0.00 | $ 0.00 | $ 0.00 |
| Gross Profit | $ -839.00K | $ -112.00K | $ -15.00K |
| Operating Income | $ -83.06M | $ -36.18M | $ -10.37M |
| EBITDA | $ -77.47M | $ -34.66M | $ -10.35M |
| Net Income | $ -78.31M | $ -34.79M | $ -10.65M |
| Balance Sheet | |||
| Cash & Short-Term Investments | $ 305.28M | $ 147.56M | $ 31.16M |
| Total Assets | $ 314.93M | $ 155.42M | $ 31.60M |
| Total Debt | $ 1.48M | $ 2.15M | $ 10.44M |
| Net Debt | $ -55.33M | $ -68.02M | $ -20.72M |
| Total Liabilities | $ 9.51M | $ 14.48M | $ 12.10M |
| Stockholders' Equity | $ 305.43M | $ 140.94M | $ 19.50M |
| Cash Flow | |||
| Free Cash Flow | $ -67.23M | $ -28.82M | $ -3.53M |
| Operating Cash Flow | $ -64.83M | $ -27.18M | $ -3.24M |
| Investing Cash Flow | $ -170.14M | $ -78.86M | $ -5.28M |
| Financing Cash Flow | $ 221.63M | $ 145.14M | $ 39.69M |